Pivot Pharmaceuticals Inc (PVOTF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PVOTF | AMGN | GILD | BIIB | CELG |
| Company | Pivot Pharmaceuticals Inc | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Celgene Corp |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.1290 | 270.63 | 66.58 | 198.97 | 108.01 |
| High | 0.1330 | 274.86 | 67.18 | 205.75 | 108.59 |
| Low | 0.1000 | 269.64 | 66.36 | 198.97 | 107.27 |
| Last | 0.1266 | 273.01 | 67.08 | 201.99 | 108.24 |
| Change | -0.0063 | -0.53 | +0.05 | +8.81 | +0.11 |
| % Change | -4.74% | -0.19% | +0.07% | +4.56% | +0.10% |
| Volume | 198,200 | 2,465,092 | 8,464,028 | 3,264,111 | 191,230,496 |
| 20-Day Average Volume | 139,665 | 2,172,604 | 6,490,386 | 1,263,921 | 16,188,930 |
| Previous Close | 0.1329 | 273.54 | 67.03 | 193.18 | 108.13 |
| Industry | Medical - Drugs | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | No |
| Technicals | |||||
| 20-Day Moving Average | 0.1572 | 271.55 | 69.07 | 202.16 | 108.17 |
| 20-Day Raw Stochastic | 31.79% | 44.22% | 14.81% | 44.61% | 63.25% |
| 20-Day Relative Strength | 49.16% | 48.18% | 33.12% | 42.70% | 64.69% |
| Weighted Alpha | -65.90 | +11.15 | -20.78 | -34.68 | +46.30 |
| Today's Opinion | 40% Buy | 40% Sell | 100% Sell | 100% Sell | 100% Buy |
| Previous Opinion | 56% Buy | 40% Sell | 100% Sell | 100% Sell | 100% Buy |
| Last Month's Opinion | 8% Buy | 24% Buy | 88% Sell | 100% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -13.76% since 06/01/20 | +3.39% since 04/17/24 | +0.22% since 04/17/24 | +5.12% since 04/17/24 | -1.97% since 11/13/19 |
| Low | 0.0650 on 06/05/20 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 189.44 on 04/19/24 | 107.27 on 11/20/19 |
| High | 0.1599 on 06/03/20 | 274.86 on 04/24/24 | 67.68 on 04/23/24 | 205.75 on 04/24/24 | 110.53 on 11/14/19 |
| 1-Month | |||||
| %Chg | -27.78% since 05/08/20 | -1.14% since 03/22/24 | -7.62% since 03/22/24 | -7.39% since 03/22/24 | +5.14% since 10/18/19 |
| Low | 0.0650 on 06/05/20 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 189.44 on 04/19/24 | 102.40 on 10/21/19 |
| High | 0.2588 on 05/18/20 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 218.26 on 03/25/24 | 110.70 on 11/13/19 |
| 3-Month | |||||
| %Chg | +80.86% since 03/06/20 | -10.64% since 01/24/24 | -15.65% since 01/24/24 | -18.28% since 01/24/24 | +13.63% since 08/20/19 |
| Low | 0.0301 on 03/23/20 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 189.44 on 04/19/24 | 93.41 on 08/23/19 |
| High | 0.2588 on 05/18/20 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 251.99 on 01/31/24 | 110.70 on 11/13/19 |
| 6-Month | |||||
| %Chg | +8.11% since 12/06/19 | -1.13% since 10/24/23 | -14.17% since 10/24/23 | -19.88% since 10/24/23 | +14.14% since 05/20/19 |
| Low | 0.0301 on 03/23/20 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 189.44 on 04/19/24 | 89.08 on 07/23/19 |
| High | 0.2850 on 12/27/19 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 268.30 on 01/03/24 | 110.70 on 11/13/19 |
| Key Statistics | |||||
| Market Capitalization, $K | 21,701 | 146,720,288 | 83,457,512 | 28,080,836 | 77,035,920 |
| Shares Outstanding, K | 171,414 | 536,376 | 1,245,077 | 145,361 | 711,714 |
| Annual Sales | 0 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 15,281,000,000 |
| Annual Net Income | -14,780,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | 4,046,000,000 |
| Last Quarter Sales | N/A | 8,196,000,000 | 7,114,000,000 | 2,386,300,000 | 4,520,000,000 |
| Last Quarter Net Income | N/A | 767,000,000 | 1,429,000,000 | 249,700,000 | 1,691,000,000 |
| 60-Month Beta | N/A | 0.58 | 0.19 | -0.02 | 1.41 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.95 on 02/13/24 | 2.99 on 10/31/19 |
| Latest Earnings Date | 06/15/20 | 05/02/24 | 04/25/24 | 04/24/24 | 10/31/19 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.58 | 9.96 | 13.18 | 10.99 |